| RS1779472995 |
CDK19
|
Health Risk |
Likely pathogenic |
— |
| RS1779473436 |
CDK19
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 87 |
| RS1779473650 |
CDK19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 87 |
| RS1779483440 |
CARD11
|
Health Risk |
Likely pathogenic |
— |
| RS1779530897 |
LAMA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1779626148 |
CARD11
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to CARD11 deficiency, BENTA disease |
| RS1779660599 |
TNXB
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Ehlers-Danlos syndrome due to tenascin-X deficiency |
| RS1779702214 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1779703136 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1779896481 |
PRKN
|
Health Risk |
Likely pathogenic |
Autosomal recessive juvenile Parkinson disease 2, Autosomal recessive juvenile Parkinson disease 2 |
| RS1779898374 |
LFNG
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 3, autosomal recessive |
| RS1779961435 |
GCM2
|
Health Risk |
Likely pathogenic |
Familial hypoparathyroidism, Familial hypoparathyroidism |
| RS1780027332 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1780098219 |
CARD11
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to CARD11 deficiency, BENTA disease |
| RS1780109910 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1780112044 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1780191273 |
CARD11
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to CARD11 deficiency, BENTA disease |
| RS1780193710 |
TRDN
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 5 |
| RS1780193930 |
CARD11
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to CARD11 deficiency, BENTA disease |
| RS1780213490 |
RMND1
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 11, Combined oxidative phosphorylation defect type 11 |
| RS1780213989 |
RMND1
|
Health Risk |
Pathogenic |
— |
| RS1780257580 |
BRAT1
|
Health Risk |
Pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1780259380 |
BRAT1
|
Health Risk |
Pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1780315559 |
TNXB
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1780336606 |
RMND1
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1780401677 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1780417016 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1780417131 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1780440992 |
CARD11;CARD11-AS1
|
Health Risk |
Likely pathogenic |
— |
| RS1780545912 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1780690164 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1780700010 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1780901751 |
EPM2A
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Lafora disease |
| RS1780924305 |
LMF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1781001592 |
UCHL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia 79A, autosomal dominant |
| RS1781002042 |
UCHL1
|
Health Risk |
Pathogenic |
Spastic paraplegia 79A, autosomal dominant |
| RS1781070341 |
UCHL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia 79A, autosomal dominant |
| RS1781162727 |
TRDN
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 5, Catecholaminergic polymorphic ventricular tachycardia 5 |
| RS1781236368 |
COXFA4
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 21 |
| RS1781327256 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1781335411 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1781395670 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1781398399 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1781452558 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1781455687 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1781468348 |
TAB2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1781476734 |
DSE
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1781486223 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1781486601 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS1781489538 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1781498987 |
LOC126859827;TAB2
|
Health Risk |
Pathogenic |
— |
| RS1781502574 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1781507295 |
DNAAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 18 |
| RS1781524947 |
TAB2
|
Health Risk |
Pathogenic |
Congenital heart defects, multiple types |
| RS1781526992 |
SASH1
|
Health Risk |
Likely pathogenic |
Dyschromatosis universalis hereditaria 1, Dyschromatosis universalis hereditaria 1 |
| RS1781533816 |
TAB2
|
Health Risk |
Likely pathogenic |
Congenital heart defects, multiple types |
| RS1781557432 |
PNLDC1
|
Health Risk |
Likely pathogenic |
Non-obstructive azoospermia, Oligospermia |
| RS1781562565 |
AHI1
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1781571282 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1781592001 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1781606569 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1781623229 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1781631365 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1781674062 |
ASCC3
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal recessive 81 |
| RS1781745482 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS1781797650 |
LAMA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1781845988 |
PMS2
|
Health Risk |
Pathogenic |
Lynch syndrome 4, Lynch syndrome 4 |
| RS1781877793 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS1781905532 |
DNAAF5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1781907458 |
DNAAF5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 18, Primary ciliary dyskinesia 18 |
| RS1781951075 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1782005506 |
IMPG1
|
Health Risk |
Pathogenic |
— |
| RS1782008883 |
IMPG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Benign concentric annular macular dystrophy, Benign concentric annular macular dystrophy |
| RS1782020453 |
IMPG1
|
Health Risk |
Pathogenic |
— |
| RS1782064827 |
PKHD1
|
Health Risk |
Pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS1782073790 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1782086229 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1782086875 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1782110783 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1782130455 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1782160930 |
PDSS2
|
Health Risk |
Likely pathogenic |
Coenzyme Q10 deficiency, primary |
| RS1782169595 |
ENPP1
|
Health Risk |
Pathogenic |
— |
| RS1782216591 |
TAB2
|
Health Risk |
Pathogenic/Likely pathogenic |
TAB2-related disorder, TAB2-related disorder |
| RS1782223593 |
TAB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects, multiple types |
| RS1782230124 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1782331450 |
LAMA2
|
Health Risk |
Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1782332430 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1782333085 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1782343581 |
BLTP1
|
Health Risk |
Likely pathogenic |
Alkuraya-Kucinskas syndrome, Alkuraya-Kucinskas syndrome |
| RS1782357136 |
ENPP1
|
Health Risk |
Pathogenic |
Hypophosphatemic rickets, autosomal recessive |
| RS1782389325 |
RARS2
|
Health Risk |
Likely pathogenic |
— |
| RS1782401252 |
RARS2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1782411099 |
TOMM7
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, Garg-Mishra progeroid syndrome |
| RS1782436364 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1782451817 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1782451970 |
ENPP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Arterial calcification, generalized |
| RS1782465728 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1782473185 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colon cancer, Hereditary nonpolyposis colorectal neoplasms |
| RS1782497993 |
DNAAF5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1782607759 |
PKHD1
|
Health Risk |
Likely pathogenic |
PKHD1-related disorder, PKHD1-related disorder |